Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.

Details

Language :

English

Volume :

4

Issue :

4

Database :

Complementary Index

Journal :

EJHaem

Publication Type :

Academic Journal

Accession number :

173777635

Full Text :

https://doi.org/10.1002/jha2.759